VERV Company Profile and Key Details

Q: Who are the executives of VERV?

Dr. Barry S. Ticho FACC, M.D., Ph.D.Chief Medical OfficerMs. Allison DorvalChief Financial Officer & Principal Accounting OfficerMr. Jason PolitiSenior Vice President of Technical OperationsDr. Anthony Philippakis M.D., Ph.D.Co-Founder & Scientific Advisory Board MemberMr. Issi Rozen M.B.A.Co-Founder & Strategic AdvisorMs. Margaret BeaudoinVice President of Fin.Dr. Burt A. Adelman M.D.Co-Founder & Independent ChairmanDr. Sekar Kathiresan M.D.Co-Founder, Chief Executive Officer & DirectorMr. Andrew D. Ashe J.D.Pres, Chief Operating Officer & Gen. CounselDr. Andrew Bellinger M.D., Ph.D.Chief Scientific Officer & Chief Medical OfficerDr. Kiran Musunuru M.D., M.P.H., Ph.D.Co-Founder & Senior Scientific Advisor

NASDAQ : VERV

Verve Therapeutics

$11.13

0.03+0.27%

At Close 4:00 PM

Not Actively Trading

61.81

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Verve Therapeutics, Inc. (VERV) stock surged +0.27%, trading at $11.13 on NASDAQ, up from the previous close of $11.10. The stock opened at $11.13, fluctuating between $11.13 and $11.13 in the recent session.

Stock Snapshot

11.1

Prev. Close

994.04M

Market Cap

11.13

Day Low

-5.274881516587678

P/E Ratio

-2.11

EPS (TTM)

-2.28

Cash Flow per Share

11.13

Open

89.31M

Number of Shares

11.13

Day High

73.19%

Free Float in %

8.6

Book Value

10.31M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 24, 2025	11.14	11.25	11.10	11.13	10.29M
Jul 23, 2025	11.11	11.14	11.08	11.10	19.89M
Jul 22, 2025	10.96	11.09	10.91	11.08	3.96M
Jul 21, 2025	10.96	11.08	10.93	10.93	2.23M
Jul 18, 2025	10.98	10.99	10.90	10.91	4.91M
Jul 17, 2025	11.01	11.05	10.93	10.95	5.61M
Jul 16, 2025	11.02	11.08	11.00	11.02	2.18M
Jul 15, 2025	11.04	11.06	11.00	11.02	3.52M
Jul 14, 2025	11.03	11.09	11.01	11.03	1.94M
Jul 11, 2025	11.06	11.09	11.02	11.03	2.42M
Jul 10, 2025	11.11	11.14	11.04	11.06	2.37M
Jul 09, 2025	11.20	11.20	11.09	11.09	2.6M
Jul 08, 2025	11.24	11.29	11.13	11.13	2.48M
Jul 07, 2025	11.24	11.30	11.16	11.16	2.48M
Jul 03, 2025	11.23	11.29	11.22	11.28	1.14M
Jul 02, 2025	11.26	11.34	11.21	11.21	3.18M
Jul 01, 2025	11.21	11.33	11.16	11.28	4.12M
Jun 30, 2025	11.27	11.33	11.17	11.23	3.22M
Jun 27, 2025	11.23	11.32	11.23	11.30	4.13M
Jun 26, 2025	11.19	11.27	11.17	11.26	4.09M

Contact Details

Boston, MA 02139

United States

https://www.vervetx.com 617 603 0070

About Company

Verve Therapeutics, Inc. is a biotechnology firm dedicated to pioneering gene-editing treatments for individuals afflicted with cardiovascular diseases. Their flagship experimental therapy, VERVE-101, represents a singular gene-editing intervention engineered to irreversibly inactivate the PCSK9 gene within the liver. The company is also progressing with an ANGPTL3 program, which similarly aims to permanently switch off the ANGPTL3 gene in the liver. To support its endeavors, Verve maintains several key partnerships, including a collaboration and licensing pact with Beam Therapeutics Inc., a development and option agreement with Acuitas Therapeutics, Inc., and a Cas9 gene-editing technology license from The Broad Institute and the President and Fellows of Harvard College. Incorporated in 2018 and headquartered in Cambridge, Massachusetts, the organization operated under the name Endcadia, Inc. until its rebranding to Verve Therapeutics, Inc. in January 2019.

Stock Peers

ARGX

-20.31-1.93%

argenx SE$1,033.15 REGN

-15.75-1.87%

Regeneron Pharmaceuticals, Inc.$827.72 VRTX

-11.84-2.12%

Vertex Pharmaceuticals Incorporated$546.12 MDGL

-1.53-0.28%

Madrigal Pharmaceuticals, Inc.$541.08 UTHR

-2.63-0.54%

United Therapeutics Corporation$487.61 ONC

-4.42-1.22%

BeOne Medicines AG$358.26 KRYS

-13.23-3.56%

Krystal Biotech, Inc.$358.24 PRAX

-3.34-0.94%

Praxis Precision Medicines, Inc.$351.81 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-4.14-1.43%

Ligand Pharmaceuticals Incorporated$285.60

Frequently Asked Questions

What is the current Verve Therapeutics, Inc. (VERV) stock price?

Verve Therapeutics, Inc. (NASDAQ: VERV) stock price is $11.13 in the last trading session. During the trading session, VERV stock reached the peak price of $11.13 while $11.13 was the lowest point it dropped to. The percentage change in VERV stock occurred in the recent session was 0.27% while the dollar amount for the price change in VERV stock was $0.03.

VERV's industry and sector of operation?

The NASDAQ listed VERV is part of Biotechnology industry that operates in the broader Healthcare sector. Verve Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VERV?

Dr. Barry S. Ticho FACC, M.D., Ph.D.
Chief Medical Officer
Ms. Allison Dorval
Chief Financial Officer & Principal Accounting Officer
Mr. Jason Politi
Senior Vice President of Technical Operations
Dr. Anthony Philippakis M.D., Ph.D.
Co-Founder & Scientific Advisory Board Member
Mr. Issi Rozen M.B.A.
Co-Founder & Strategic Advisor
Ms. Margaret Beaudoin
Vice President of Fin.
Dr. Burt A. Adelman M.D.
Co-Founder & Independent Chairman
Dr. Sekar Kathiresan M.D.
Co-Founder, Chief Executive Officer & Director
Mr. Andrew D. Ashe J.D.
Pres, Chief Operating Officer & Gen. Counsel
Dr. Andrew Bellinger M.D., Ph.D.
Chief Scientific Officer & Chief Medical Officer
Dr. Kiran Musunuru M.D., M.P.H., Ph.D.
Co-Founder & Senior Scientific Advisor

How VERV did perform over past 52-week?

VERV's closing price is 288.48% higher than its 52-week low of $2.87 where as its distance from 52-week high of $11.41 is -2.41%.

How many employees does VERV have?

Number of VERV employees currently stands at 274.

Link for VERV official website?

Official Website of VERV is: https://www.vervetx.com

How do I contact VERV?

VERV could be contacted at phone 617 603 0070 and can also be accessed through its website. VERV operates from 500 Technology Square, Boston, MA 02139, United States.

How many shares of VERV are traded daily?

VERV stock volume for the day was 10.31M shares. The average number of VERV shares traded daily for last 3 months was 5.72M.

What is the market cap of VERV currently?

The market value of VERV currently stands at $994.04M with its latest stock price at $11.13 and 89.31M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	274
Beta	2.24
Sales or Revenue	$11.76M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	274
Beta	2.24
Sales or Revenue	$11.76M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

VERV Company Profile and Key Details

Verve Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Valuation Metrics

Price Forecast & Outlook

Key Takeaways